Steve E. Krognes - 16 Sep 2026 Form 4 Insider Report for Guardant Health, Inc. (GH)

Reporting relationship: Director
Issuer ticker: GH
Reported as of: 16 Sep 2026
Net transaction value: -$1,172,886
SEC form: 4
Accepted by SEC: 17 Sep 2026, 17:10:38 UTC
Prior SEC filing: 02 Jul 2026
Source filing: View source filing
Reporting owner signature: /s/ John Saia, as attorney-in-fact for Steve Krognes

Key filing fact

Steve E. Krognes filed Form 4 for Guardant Health, Inc. (GH) on 17 Sep 2026.

Key facts

This page summarizes Steve E. Krognes's Form 4 filing for Guardant Health, Inc. (GH).
4 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 17 Sep 2026, 17:10.

Change

Previous filing in this sequence was filed on 02 Jul 2026.
Current net transaction value: -$1,172,886.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001666236 Primary reporting owner

Krognes Steve E.

Relationship: Director
Address: 3100 HANOVER STREET, PALO ALTO
Signature: /s/ John Saia, as attorney-in-fact for Steve Krognes
Signature date: 17 Sep 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

GH transaction

Common Stock

Sale

Transaction value: $192,432
Shares: -1,103
Change %: -7.6%
Price: $174.46
Shares after: 13,477
Date: 16 Sep 2026
Ownership: Direct
Footnotes: F1

GH transaction

Common Stock

Sale

Transaction value: $578,888
Shares: -3,300
Change %: -24%
Price: $175.42
Shares after: 10,177
Date: 16 Sep 2026
Ownership: Direct
Footnotes: F2

GH transaction

Common Stock

Sale

Transaction value: $229,236
Shares: -1,300
Change %: -13%
Price: $176.34
Shares after: 8,877
Date: 16 Sep 2026
Ownership: Direct
Footnotes: F3

GH transaction

Common Stock

Sale

Transaction value: $172,330
Shares: -971
Change %: -11%
Price: $177.48
Shares after: 7,906
Date: 16 Sep 2026
Ownership: Direct
Footnotes: F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $173.98 to $174.975. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.

Footnote F2

Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $175.02 to $176.01. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.

Footnote F3

Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $176.055 to $176.88. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.

Footnote F4

Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $177.08 to $177.945. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.